Skip to main content

Animations

MJFF Publications

6951 - 6960 of 8826 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Safety and Feasibility of Serial Lumbar Punctures: Long-term Results from the Parkinson’s Progression Markers Initiative
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100385
    Citation Count: 0
  • Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum
    2025
    Summary Details
    RESTRICTED
    Title: Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2025.02.014
    Citation Count: 45
  • Summary Details
    OPEN
    Title: A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progression
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-025-00926-x
    Citation Count: 5
  • Summary Details
    OPEN
    Title: The Exon-Based Transcriptomic Analysis of Parkinson’s Disease
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3390/biom15030440
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Virtual Compound Screening for Discovery of Dopamine D1 Receptor Biased Allosteric Modulators
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00972
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-00896-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acsnano.4c15013
    Citation Count: 22
  • Summary Details
    OPEN
    Title: A common mechanism of singular gene choice is revealed by broadly expressed odorant receptor transgenes within the olfactory epithelium
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115955
    Citation Count: 3
  • Summary Details
    OPEN
    Title: PPM1M, an LRRK2-counteracting, phosphoRab12-preferring phosphatase with a potential link to Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.116031
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-024-12836-w
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.